Drug application
INTAL (CROMOLYN SODIUM)
Drugs@FDA NDA 016990 · SANOFI AVENTIS US
Key facts
| Drug name | INTAL |
|---|---|
| Active ingredients | CROMOLYN SODIUM |
| Application type | NDA |
| Application number | 016990 |
| Company | SANOFI AVENTIS US |
| Dosage forms | CAPSULE, INHALATION |
| Strength | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
At a glance
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.